1 day+0.17%
1 week+0.17%
Current month+9.09%
1 month+1.69%
6 months-14.29%
Current year+9.49%
1 week 1,100
Extreme 1100
1,200
1 month 1,063
Extreme 1063
1,384
Current year 805
Extreme 805
1,600
1 year 805
Extreme 805
1,600
3 years 805
Extreme 805
2,390
5 years 805
Extreme 805
4,500
10 years 805
Extreme 805
7,430
Manager TitleAgeSince
Chief Executive Officer 64 -
Chief Tech/Sci/R&D Officer 61 24/03/2025
Corporate Officer/Principal 60 -
Director TitleAgeSince
Director/Board Member 64 -
Director/Board Member 60 -
Director/Board Member 61 24/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+0.17%+9.49%-40.00% 49.5L
+0.13%+2.65%+65.61%+114.28% 1,05500Cr
+0.20%+0.46%+52.60%+69.24% 65TCr
-0.29%+0.14%+20.96%+70.93% 47TCr
-0.85%+0.98%+41.29%+44.38% 35TCr
+0.71%+4.08%+22.24%+29.51% 27TCr
+1.23%+0.42%+14.57%+12.13% 26TCr
+2.11%+7.51%+52.89%+55.37% 22TCr
+0.83%+0.55%+35.99%+101.70% 19TCr
0.00%-10.14%-29.94%-60.30% 17TCr
Average +0.34%+0.67%+28.57%+39.72% 36.38TCr
Weighted average by Cap. +0.02%+1.32%+41.54%+67.83%

Financials

2014 2015
Net sales 644.89Cr 8,75400Cr 565.89Cr 534.46Cr 487.06Cr 911.75Cr 62TCr 918.26Cr 6.4TCr 2.48TCr 32TCr 2.42TCr 2.37TCr 1,01500Cr 728.14Cr 9,88400Cr 638.94Cr 603.45Cr 549.93Cr 1.03TCr 70TCr 1.04TCr 7.22TCr 2.8TCr 36TCr 2.73TCr 2.67TCr 1,14600Cr
Net income 16Cr 21TCr 14Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 153.96Cr 60Cr 760.14Cr 58Cr 57Cr 2.44TCr -132.12Cr -1,79300Cr -115.94Cr -109.5Cr -100Cr -186.79Cr -13TCr -188.13Cr -1.31TCr -507.5Cr -6.47TCr -496.06Cr -485.33Cr -21TCr
Net Debt - -
Logo Genotech Corporation
Genotech Corporation is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) & Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results.
Employees
-
Date Price Change Volume
21/26/21 ₩1,200.00 +0.17% 11
18/26/18 ₩1,198.00 -4.16% 12
  1. Stock Market
  2. Stocks
  3. A066830 Stock